2 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Unknown 2 |
Follow Camurati-Engelmann Syndrome: new trials by email Literature Review of Camurati-Engelmann Syndrome trials Research Report on Camurati-Engelmann Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct Colchicine, Percutaneous Coronary Intervention, Optimal medical treatment including statin, aspirin, P2Y12 inhibitor, and nitrate. - ST Elevation Myocardial Infarction, Colchicine | Phase 4 | Unknown | RSD dr. Soebandi | 148 | 2022-06-01 | 2023-04-11 |
| A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy aliskiren - Glomerulonephritis, IGA, Hypertension | Phase 4 | Unknown | Kagawa University | 30 | 2010-06-01 | 2011-06-27 |
Albuminuria (1) · Glomerulonephritis, IGA (1) · Hypertension (1) · ST Elevation Myocardial Infarction (1) · Ventricular Remodeling (1)
Bone Diseases (2) · Bone Diseases, Developmental (2) · Cardiovascular Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Musculoskeletal Diseases (2) · Osteochondrodysplasias (2) · Pathological Conditions, Signs and Symptoms (2) · Vascular Diseases (2) · Autoimmune Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Glomerulonephritis (1) · Heart Diseases (1) · Immune System Diseases (1)
Aspirin (1) · Colchicine (1) · Nitrates (1) · Percutaneous Coronary Intervention (1) · aliskiren (1)
Kagawa University (1) · RSD dr. Soebandi (1)
Indonesia (1) · Japan (1)